Beta-Cell Apoptosis in Diabetes

Beta-cell apoptosis, or programmed cell death, is a significant factor contributing to the progression of diabetes, particularly type 1 and type 2 diabetes. Various stressors, including chronic hyperglycemia, lipotoxicity, and autoimmune responses, can trigger apoptosis, leading to a decline in insulin-producing cells. The loss of beta cells reduces insulin secretion, exacerbating hyperglycemia and metabolic dysfunction. Research is focused on identifying protective mechanisms and potential therapeutic targets to prevent beta-cell death. Strategies may include the use of anti-apoptotic agents, lifestyle interventions, and immunotherapies, all aiming to preserve beta-cell mass and enhance insulin production in diabetic patients.

Committee Members
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes  2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes  2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp